Orphan drug designation, or ODD, is valuable on both a humanitarian and a profitability basis. And this company is seeing shares rally following news that it was granted the designation for the...

To read the full story on AllPennyStocks.com, click here.

Cardiol Therapeutics (TSX:CRDL)
過去 株価チャート
から 11 2024 まで 12 2024 Cardiol Therapeuticsのチャートをもっと見るにはこちらをクリック
Cardiol Therapeutics (TSX:CRDL)
過去 株価チャート
から 12 2023 まで 12 2024 Cardiol Therapeuticsのチャートをもっと見るにはこちらをクリック